Home Bridge Bio

Bridge Bio

In operation
IPO
Innovative Drug Developer

Basic Information

Bridge Biotherapeutics, a biotech company focused on developing innovative new drugs, aims to treat diseases with high unmet medical needs by designing transformative therapies for genetic disorders and cancers with well-defined genetic drivers.
Bridge Biotherapeutics, Inc.
Seongnam,GyeonggiProvince,SouthKorea
15~50 people
January 01, 2015
Jong-jin.lim@bridgebiorx.com